Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Anavex Life Sciences Corp have a median target of 40.45, with a high estimate of 46.00 and a low estimate of 15.00. The median estimate represents a 348.45% increase from the last price of 9.02.
High | 410.0% | 46.00 |
Med | 348.4% | 40.45 |
Low | 66.3% | 15.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 25, 2024.
Average growth rate | -0.81% |
Average growth rate | -3.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼